Immunohistochemical (IHC) analysis of the ten pairs of bladder cancer tissues indicated a heightened expression of DARS2 in bladder cancer compared to normal bladder mucosal epithelial tissues (P<0.05, Figures 1G, H). This evidence concerns the gene DARS2 and urinary bladder carcinoma.